Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Meningococcal Immunisation, Healthy Volunteers

In brief

The purpose of VAN00010 study is to assess the safety and immunogenicity of the investigational pentavalent meningococcal ABCYW vaccine in adults and adolescents. The study duration will be up to 12 months for all participants.

Key facts

Study ID
NCT06128733
Run by
Sanofi Pasteur, a Sanofi Company
People needed
1215
Starts
2023-10-31
Expected to finish
2025-08-27
Last updated by the study team
2026-01-13

Who can join

Age: 10 and older, up to 25. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.